Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

Implementation of a sentinel lymph node mapping algorithm for endometrial cancer: surgical outcomes and hospital charges.

Stewart KI, Eska JS, Harrison RF, Suidan R, Abraham A, Chisholm GB, Meyer LA, Westin SN, Fleming ND, Frumovitz M, Aloia TA, Soliman PT.

Int J Gynecol Cancer. 2020 Jan 6. pii: ijgc-2019-000941. doi: 10.1136/ijgc-2019-000941. [Epub ahead of print]

PMID:
31911539
2.

Everolimus, Letrozole, and Metformin in Women with Advanced or Recurrent Endometrioid Endometrial Cancer: A Multi-Center, Single Arm, Phase II Study.

Soliman PT, Westin SN, Iglesias DA, Fellman BM, Yuan Y, Zhang Q, Yates MS, Broaddus RR, Slomovitz BM, Lu KH, Coleman RL.

Clin Cancer Res. 2020 Feb 1;26(3):581-587. doi: 10.1158/1078-0432.CCR-19-0471. Epub 2019 Oct 18.

PMID:
31628143
3.

Systematic Approach to Selecting and Preparing a Medical Power of Attorney in the Gynecologic Oncology Center.

Zhukovsky DS, Soliman PT, Mathew B, Mills S, Bodurka D, Frumovitz M, Meyer LA, Westin S, Nowitz M, Archie L, Fenton S, Lang K, Williams JL, Boving V, Bruera E.

J Oncol Pract. 2019 Dec;15(12):e1092-e1097. doi: 10.1200/JOP.19.00109. Epub 2019 Oct 15.

PMID:
31613720
4.

Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer.

Matsuo K, Cripe JC, Kurnit KC, Kaneda M, Garneau AS, Glaser GE, Nizam A, Schillinger RM, Kuznicki ML, Yabuno A, Yanai S, Garofalo DM, Suzuki J, St Laurent JD, Yen TT, Liu AY, Shida M, Kakuda M, Oishi T, Nishio S, Marcus JZ, Adachi S, Kurokawa T, Ross MS, Horowitz MP, Johnson MS, Kim MK, Melamed A, Machado KK, Yoshihara K, Yoshida Y, Enomoto T, Ushijima K, Satoh S, Ueda Y, Mikami M, Rimel BJ, Stone RL, Growdon WB, Okamoto A, Guntupalli SR, Hasegawa K, Shahzad MMK, Im DD, Frimer M, Gostout BS, Ueland FR, Nagao S, Soliman PT, Thaker PH, Wright JD, Roman LD.

Gynecol Oncol. 2019 Oct;155(1):39-50. doi: 10.1016/j.ygyno.2019.08.007. Epub 2019 Aug 16.

PMID:
31427143
5.

Preoperative PET/CT does not accurately detect extrauterine disease in patients with newly diagnosed high-risk endometrial cancer: A prospective study.

Stewart KI, Chasen B, Erwin W, Fleming N, Westin SN, Dioun S, Frumovitz M, Ramirez PT, Lu KH, Wong F, Aloia TA, Soliman PT.

Cancer. 2019 Oct 1;125(19):3347-3353. doi: 10.1002/cncr.32329. Epub 2019 Jun 21.

PMID:
31225906
6.

Clinicopathologic features and treatment in patients with early stage uterine clear cell carcinoma: A 16-year experience.

Armbruster SD, Previs R, Soliman PT, Westin SN, Fellman B, Jhingran A, Fleming ND.

Gynecol Oncol. 2019 Aug;154(2):328-332. doi: 10.1016/j.ygyno.2019.06.001. Epub 2019 Jun 18.

PMID:
31221496
7.

Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer.

Chapman BV, Swanick CW, Ning MS, Allen PK, Soliman PT, Westin SN, Pardeshi V, Broaddus RR, Lu KH, Jhingran A, Eifel PJ, Klopp AH.

Gynecol Oncol. 2019 Jul;154(1):22-28. doi: 10.1016/j.ygyno.2019.05.002. Epub 2019 May 17.

PMID:
31109659
8.

Hypomagnesemia and Survival in Patients with Ovarian Cancer Who Received Chemotherapy with Carboplatin.

Liu W, Qdaisat A, Soliman PT, Ramondetta L, Lopez G, Narayanan S, Zhou S, Cohen L, Bruera E, Yeung SJ.

Oncologist. 2019 Jun;24(6):e312-e317. doi: 10.1634/theoncologist.2018-0465. Epub 2019 Apr 2.

9.

Factors influencing the adoption of the sentinel lymph node technique for endometrial cancer staging: an international survey of gynecologic oncologists.

Casarin J, Multinu F, Abu-Rustum N, Cibula D, Cliby WA, Ghezzi F, Leitao M, Konishi I, Nam JH, Querleu D, Soliman PT, Yost KJ, Weaver AL, Mariani A, Glaser GE.

Int J Gynecol Cancer. 2019 Jan;29(1):60-67. doi: 10.1136/ijgc-2018-000020.

10.

Prognostic factors impacting survival in early stage uterine carcinosarcoma.

Kurnit KC, Previs RA, Soliman PT, Westin SN, Klopp AH, Fellman BM, Lu KH, Ramondetta LM, Fleming ND.

Gynecol Oncol. 2019 Jan;152(1):31-37. doi: 10.1016/j.ygyno.2018.10.034. Epub 2018 Nov 8.

11.

Concordance of a laparoscopic scoring algorithm with primary surgery findings in advanced stage ovarian cancer.

Hansen JM, Sood AK, Coleman RL, Westin SN, Soliman PT, Ramirez PT, Fellman BM, Schmeler KM, Fleming ND.

Gynecol Oncol. 2018 Dec;151(3):428-432. doi: 10.1016/j.ygyno.2018.10.017. Epub 2018 Oct 23.

12.

Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy.

Roszik J, Ring KL, Wani KM, Lazar AJ, Yemelyanova AV, Soliman PT, Frumovitz M, Jazaeri AA.

Front Immunol. 2018 Sep 19;9:2102. doi: 10.3389/fimmu.2018.02102. eCollection 2018.

13.

A practical guide for the safe implementation of early phase drug development and immunotherapy program in gynecologic oncology practice.

Jazaeri A, Coleman RL, Sood AK, Frumovitz MM, Soliman PT, Shafer A, Cutrera JJ, Klinger M, Sharafi SE, Johnson CAL, Villanueva VF, Hinchcliff EM, Dickens A, Cain KE, Anderson JE, Lu KH, Westin SN.

Gynecol Oncol. 2018 Nov;151(2):374-380. doi: 10.1016/j.ygyno.2018.08.037. Epub 2018 Sep 10. Review.

14.

Race and nodal disease status are prognostic factors in patients with stage IVB cervical cancer.

Nishio S, Matsuo K, Yonemoto K, Shimokawa M, Hosaka M, Kodama M, Miyake TM, Ushijima K, Kamura T, Westin SN, Soliman PT, Coleman RL.

Oncotarget. 2018 Aug 17;9(64):32321-32330. doi: 10.18632/oncotarget.25962. eCollection 2018 Aug 17.

15.

Laparoscopic Surgical Algorithm to Triage the Timing of Tumor Reductive Surgery in Advanced Ovarian Cancer.

Fleming ND, Nick AM, Coleman RL, Westin SN, Ramirez PT, Soliman PT, Fellman B, Meyer LA, Schmeler KM, Lu KH, Sood AK.

Obstet Gynecol. 2018 Sep;132(3):545-554. doi: 10.1097/AOG.0000000000002796.

16.

The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer.

Jalloul RJ, Nick AM, Munsell MF, Westin SN, Ramirez PT, Frumovitz M, Soliman PT.

J Gynecol Oncol. 2018 Sep;29(5):e68. doi: 10.3802/jgo.2018.29.e68. Epub 2018 May 4.

17.

Can MRI help assess aggressiveness of endometrial cancer?

Ahmed M, Al-Khafaji JF, Class CA, Wei W, Ramalingam P, Wakkaa H, Soliman PT, Frumovitz M, Iyer RB, Bhosale PR.

Clin Radiol. 2018 Sep;73(9):833.e11-833.e18. doi: 10.1016/j.crad.2018.05.002. Epub 2018 Jun 9.

PMID:
29895385
18.

Three Lymphadenectomy Strategies in Low-Risk Endometrial Carcinoma: A Cost-Effectiveness Analysis.

Suidan RS, Sun CC, Cantor SB, Mariani A, Soliman PT, Westin SN, Lu KH, Giordano SH, Meyer LA.

Obstet Gynecol. 2018 Jul;132(1):52-58. doi: 10.1097/AOG.0000000000002677.

19.

Prospective assessment of patient-reported outcomes in gynecologic cancer patients before and after pelvic exenteration.

Armbruster SD, Sun CC, Westin SN, Bodurka DC, Ramondetta L, Meyer LA, Soliman PT.

Gynecol Oncol. 2018 Jun;149(3):484-490. doi: 10.1016/j.ygyno.2018.03.054. Epub 2018 Apr 2.

20.

Minimally invasive hysterectomy surgery rates for endometrial cancer performed at National Comprehensive Cancer Network (NCCN) Centers.

Bergstrom J, Aloisi A, Armbruster S, Yen TT, Casarin J, Leitao MM Jr, Tanner EJ, Matsuno R, Machado KK, Dowdy SC, Soliman PT, Wethington SL, Stone RL, Levinson KL, Fader AN.

Gynecol Oncol. 2018 Mar;148(3):480-484. doi: 10.1016/j.ygyno.2018.01.002. Epub 2018 Jan 12.

21.

Setting Benchmarks for the New User: Training on the Robotic Simulator.

Dioun SM, Fleming ND, Munsell MF, Lee J, Ramirez PT, Soliman PT.

JSLS. 2017 Oct-Dec;21(4). pii: e2017.00059. doi: 10.4293/JSLS.2017.00059.

22.

Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device.

Pal N, Broaddus RR, Urbauer DL, Balakrishnan N, Milbourne A, Schmeler KM, Meyer LA, Soliman PT, Lu KH, Ramirez PT, Ramondetta L, Bodurka DC, Westin SN.

Obstet Gynecol. 2018 Jan;131(1):109-116. doi: 10.1097/AOG.0000000000002390.

23.

Risk of Subsequent Ovarian Cancer After Ovarian Conservation in Young Women With Stage I Endometrioid Endometrial Cancer.

Matsuo K, Machida H, Stone RL, Soliman PT, Thaker PH, Roman LD, Wright JD.

Obstet Gynecol. 2017 Aug;130(2):403-410. doi: 10.1097/AOG.0000000000002142.

PMID:
28697110
24.

Should We Perform Routine Peritoneal and Staging Biopsies at the Time of Risk-reducing Bilateral Salpingo-ophrectomy?

Soliman PT.

J Minim Invasive Gynecol. 2017 Jul - Aug;24(5):691. doi: 10.1016/j.jmig.2017.05.009. Epub 2017 May 20. No abstract available. Erratum in: J Minim Invasive Gynecol. 2018 Jan;25(1):191.

PMID:
28536074
25.

A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer.

Soliman PT, Westin SN, Dioun S, Sun CC, Euscher E, Munsell MF, Fleming ND, Levenback C, Frumovitz M, Ramirez PT, Lu KH.

Gynecol Oncol. 2017 Aug;146(2):234-239. doi: 10.1016/j.ygyno.2017.05.016. Epub 2017 May 18.

26.

Factors prognostic of survival in advanced-stage uterine serous carcinoma.

Holman LL, Pal N, Iglesias DA, Soliman PT, Balakrishnan N, Klopp A, Broaddus RR, Fleming ND, Munsell MF, Lu KH, Westin SN.

Gynecol Oncol. 2017 Jul;146(1):27-33. doi: 10.1016/j.ygyno.2017.04.018. Epub 2017 Apr 30.

27.

Cancer Genomics and Important Oncologic Mutations: A Contemporary Guide for Body Imagers.

Cox VL, Bhosale P, Varadhachary GR, Wagner-Bartak N, Glitza IC, Gold KA, Atkins JT, Soliman PT, Hong DS, Qayyum A.

Radiology. 2017 May;283(2):314-340. doi: 10.1148/radiol.2017152224. Review.

PMID:
28418819
28.

Potential immunotherapy targets in recurrent cervical cancer.

Ring KL, Yemelyanova AV, Soliman PT, Frumovitz MM, Jazaeri AA.

Gynecol Oncol. 2017 Jun;145(3):462-468. doi: 10.1016/j.ygyno.2017.02.027. Epub 2017 Feb 21.

PMID:
28233576
29.

Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer.

Salvo G, Ramirez PT, Levenback CF, Munsell MF, Euscher ED, Soliman PT, Frumovitz M.

Gynecol Oncol. 2017 Apr;145(1):96-101. doi: 10.1016/j.ygyno.2017.02.005. Epub 2017 Feb 8.

30.

Impact of body mass index and operative approach on surgical morbidity and costs in women with endometrial carcinoma and hyperplasia.

Suidan RS, He W, Sun CC, Zhao H, Fleming ND, Ramirez PT, Soliman PT, Westin SN, Lu KH, Giordano SH, Meyer LA.

Gynecol Oncol. 2017 Apr;145(1):55-60. doi: 10.1016/j.ygyno.2017.01.025. Epub 2017 Jan 26.

31.

Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study.

Soliman PT, Zhang Q, Broaddus RR, Westin SN, Iglesias D, Munsell MF, Schmandt R, Yates M, Ramondetta L, Lu KH.

Gynecol Oncol. 2016 Dec;143(3):466-471. doi: 10.1016/j.ygyno.2016.10.011. Epub 2016 Oct 13.

32.

Quality of life after radical trachelectomy for early-stage cervical cancer: A 5-year prospective evaluation.

Fleming ND, Ramirez PT, Soliman PT, Schmeler KM, Chisholm GB, Nick AM, Westin SN, Frumovitz M.

Gynecol Oncol. 2016 Dec;143(3):596-603. doi: 10.1016/j.ygyno.2016.10.012. Epub 2016 Oct 11.

33.

Endometrial Cancer Associated Symptoms: A Case-Control Study.

Pakish JB, Lu KH, Sun CC, Burzawa JK, Greisinger A, Smith FA, Fellman B, Urbauer DL, Soliman PT.

J Womens Health (Larchmt). 2016 Nov;25(11):1187-1192. Epub 2016 Jun 2.

34.

Role of cervical cytology in surveillance after radical trachelectomy for cervical cancer.

Brown AJ, Shah JS, Fleming ND, Nick AM, Soliman PT, Chisholm GB, Schmeler KM, Ramirez PT, Frumovitz M.

Gynecol Oncol. 2016 Aug;142(2):283-5. doi: 10.1016/j.ygyno.2016.05.030. Epub 2016 Jun 6.

35.

Loss of p27 Associated with Risk for Endometrial Carcinoma Arising in the Setting of Obesity.

McCampbell AS, Mittelstadt ML, Dere R, Kim S, Zhou L, Djordjevic B, Soliman PT, Zhang Q, Wei C, Hursting SD, Lu KH, Broaddus RR, Walker CL.

Curr Mol Med. 2016;16(3):252-65.

36.

Fighting cancer together: Development and implementation of shared medical appointments to standardize and improve chemotherapy education.

Prescott LS, Dickens AS, Guerra SL, Tanha JM, Phillips DG, Patel KT, Umberson KM, Lozano MA, Lowe KB, Brown AJ, Taylor JS, Soliman PT, Garcia EA, Levenback CF, Bodurka DC.

Gynecol Oncol. 2016 Jan;140(1):114-9. doi: 10.1016/j.ygyno.2015.11.006. Epub 2015 Nov 5.

37.

Role of Indocyanine Green in Sentinel Node Mapping in Gynecologic Cancer: Is Fluorescence Imaging the New Standard?

Darin MC, Gómez-Hidalgo NR, Westin SN, Soliman PT, Escobar PF, Frumovitz M, Ramirez PT.

J Minim Invasive Gynecol. 2016 Feb 1;23(2):186-93. doi: 10.1016/j.jmig.2015.10.011. Epub 2015 Oct 28. Review.

PMID:
26518716
38.
39.

Impact of Lymph Node Ratio and Adjuvant Therapy in Node-Positive Endometrioid Endometrial Cancer.

Fleming ND, Soliman PT, Westin SN, dos Reis R, Munsell M, Klopp AH, Frumovitz M, Nick AM, Schmeler K, Ramirez PT.

Int J Gynecol Cancer. 2015 Oct;25(8):1437-44. doi: 10.1097/IGC.0000000000000510.

40.

Improvement in quality of life after robotic surgery results in patient satisfaction.

Arms RG 3rd, Sun CC, Burzawa JK, Fleming ND, Nick AM, Rallapalli V, Westin SN, Meyer LA, Ramirez PT, Soliman PT.

Gynecol Oncol. 2015 Sep;138(3):727-30. doi: 10.1016/j.ygyno.2015.07.013. Epub 2015 Jul 18.

41.

Laparoscopic hysterectomy with morcellation for a suspected uterine fibroid resulting in dissemination of cervical adenocarcinoma: A case report.

Dioun SM, Soliman PT.

Gynecol Oncol Rep. 2015 Jan 28;12:5-6. doi: 10.1016/j.gore.2014.12.001. eCollection 2015 Apr.

42.

Response to MEK inhibitor in small cell neuroendocrine carcinoma of the cervix with a KRAS mutation.

Lyons YA, Frumovitz M, Soliman PT.

Gynecol Oncol Rep. 2014 Oct 25;10:28-9. doi: 10.1016/j.gore.2014.09.003. eCollection 2014 Dec.

43.

Isolated port-site metastases after minimally invasive hysterectomy for endometrial cancer: outcomes of patients treated with radiotherapy.

Grant JD, Garg AK, Gopal R, Soliman PT, Jhingran A, Eifel PJ, Klopp AH.

Int J Gynecol Cancer. 2015 Jun;25(5):869-74. doi: 10.1097/IGC.0000000000000424.

PMID:
25790043
44.

Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma.

Slomovitz BM, Jiang Y, Yates MS, Soliman PT, Johnston T, Nowakowski M, Levenback C, Zhang Q, Ring K, Munsell MF, Gershenson DM, Lu KH, Coleman RL.

J Clin Oncol. 2015 Mar 10;33(8):930-6. doi: 10.1200/JCO.2014.58.3401. Epub 2015 Jan 26.

45.

Significance of lymph node ratio in defining risk category in node-positive early stage cervical cancer.

Fleming ND, Frumovitz M, Schmeler KM, dos Reis R, Munsell MF, Eifel PJ, Soliman PT, Nick AM, Westin SN, Ramirez PT.

Gynecol Oncol. 2015 Jan;136(1):48-53. doi: 10.1016/j.ygyno.2014.11.010. Epub 2014 Nov 18.

46.

Position-related injury is uncommon in robotic gynecologic surgery.

Ulm MA, Fleming ND, Rallapali V, Munsell MF, Ramirez PT, Westin SN, Nick AM, Schmeler KM, Soliman PT.

Gynecol Oncol. 2014 Dec;135(3):534-8. doi: 10.1016/j.ygyno.2014.10.016. Epub 2014 Oct 23.

47.

Uterine adenosarcoma: an analysis on management, outcomes, and risk factors for recurrence.

Carroll A, Ramirez PT, Westin SN, Soliman PT, Munsell MF, Nick AM, Schmeler KM, Klopp AH, Fleming ND.

Gynecol Oncol. 2014 Dec;135(3):455-61. doi: 10.1016/j.ygyno.2014.10.022. Epub 2014 Oct 28.

48.

Morbid obesity as an independent risk factor for disease-specific mortality in women with cervical cancer.

Frumovitz M, Jhingran A, Soliman PT, Klopp AH, Schmeler KM, Eifel PJ.

Obstet Gynecol. 2014 Dec;124(6):1098-104. doi: 10.1097/AOG.0000000000000558.

49.

Risk factors for the development of uterine cancer in breast cancer survivors: an army of women study.

Torres D, Myers JA, Eshraghi LW, Riley EC, Soliman PT, Milam MR.

Ann Surg Oncol. 2015;22(6):1974-9. doi: 10.1245/s10434-014-4193-5. Epub 2014 Nov 1.

PMID:
25361886
50.

Clinically significant endometrial cancer risk following a diagnosis of complex atypical hyperplasia.

Costales AB, Schmeler KM, Broaddus R, Soliman PT, Westin SN, Ramirez PT, Frumovitz M.

Gynecol Oncol. 2014 Dec;135(3):451-4. doi: 10.1016/j.ygyno.2014.10.008. Epub 2014 Oct 12.

Supplemental Content

Loading ...
Support Center